SLC16A1 and Parkinson disease: These genes are members of multiple metabolic pathways and processes, including lipid metabolism (SCD, FGFBP3) and mitochondrial pathways (MT-ND2, SLC16A1, PPA2, FDPS), which have previously been implicated in AD and PD [36].